Peter Trent - Atlas Arteria CEO
| MAQAF Stock | USD 3.45 0.04 1.17% |
CEO
Mr. Peter Trent is no longer as Chief Executive Officer at Macquarie Atlas Roads Group, effective 1 February 2018. He is currently an Executive Director with Macquarie, having held senior advisory and fund management roles for Macquarie in both Europe and in Australia over the past 12 years. He has over 25 years of infrastructure and capital markets experience covering a range of investment transactions, principally within the transport sector. He was involved in the development, management, operation and financing of toll roads in Australia, Europe and North America over the past 18 years and was previously head of European toll roads advisory within the Macquarie Group in London, where he was involved in the bidding and development of toll roads across Europe on behalf of European concessionaires. Prior to joining Macquarie, he was an Executive Vice President with Bankers Trust Australia. since 2013.
| Age | 58 |
| Tenure | 11 years |
| Phone | 61 4 3849 3692 |
| Web | https://www.atlasarteria.com |
Atlas Arteria Management Efficiency
Atlas Arteria's management efficiency ratios could be used to measure how well Atlas Arteria manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| David Roberts | Verra Mobility Corp | 52 | |
| Mark Stone | Verra Mobility Corp | 52 | |
Management Performance
| Return On Equity | 0.0695 | |||
| Return On Asset | -0.0025 |
Atlas Arteria Limited Leadership Team
Elected by the shareholders, the Atlas Arteria's board of directors comprises two types of representatives: Atlas Arteria inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atlas. The board's role is to monitor Atlas Arteria's management team and ensure that shareholders' interests are well served. Atlas Arteria's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atlas Arteria's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Debra Goodin, Director | ||
| Navleen Prasad, Public Affairs Manager | ||
| BCom BCom, Company Counsel | ||
| LLB BCom, Joint Sec | ||
| David Bartholomew, Independent Director | ||
| David Collins, Chief Officer | ||
| Nadine Lennie, CFO | ||
| Jeffrey Conyers, Independent Director | ||
| Richard England, Non-Executive Independent Director | ||
| Peter Trent, CEO | ||
| Lyndal Coates, Company Secretary | ||
| JeanGeorges Malcor, Director | ||
| James Hooke, CEO | ||
| Marc Cure, Independent Director | ||
| Nora Scheinkestel, Non-Executive Director | ||
| Lovaine Parkes, Company Secretary | ||
| Clayton McCormack, General Counsel, General Secretary | ||
| Ryan CFA, Specialist Analysis | ||
| Christopher Leslie, Director | ||
| James Keyes, Independent Director | ||
| Debbie Goodin, Non-Executive Independent Director | ||
| Tess Palmer, Director Relations | ||
| Chloe Ranicar, Ma Relations | ||
| Mark Goodrick, CFO | ||
| Graeme Bevans, CEO MD | ||
| John Roberts, Non-Independent Non-Executive Director | ||
| Vincent PortalBarrault, Chief Officer | ||
| Christine Williams, Company Secretary | ||
| Derek Stapley, Non-Executive Independent Director |
Atlas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Atlas Arteria a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0695 | |||
| Return On Asset | -0.0025 | |||
| Profit Margin | 2.33 % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 7.66 B | |||
| Shares Outstanding | 1.45 B | |||
| Shares Owned By Insiders | 18.43 % | |||
| Shares Owned By Institutions | 53.57 % | |||
| Price To Earning | 29.15 X | |||
| Price To Book | 2.94 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atlas Arteria in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atlas Arteria's short interest history, or implied volatility extrapolated from Atlas Arteria options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Atlas Arteria Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Atlas Arteria Limited information on this page should be used as a complementary analysis to other Atlas Arteria's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Atlas Pink Sheet analysis
When running Atlas Arteria's price analysis, check to measure Atlas Arteria's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atlas Arteria is operating at the current time. Most of Atlas Arteria's value examination focuses on studying past and present price action to predict the probability of Atlas Arteria's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atlas Arteria's price. Additionally, you may evaluate how the addition of Atlas Arteria to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |